ACIU Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
AC Immune SA (ACIU) is not a strong buy for a beginner, long-term investor at this time. The lack of positive trading signals, weak financial performance, and absence of significant positive catalysts suggest that it is better to hold off on investing in this stock for now.
The MACD histogram is negative and expanding, indicating a bearish trend. RSI is neutral at 43.643, and moving averages are converging, showing no clear trend. The stock is trading below key pivot levels, with support at 2.808 and resistance at 3.062.
NULL identified. No recent news or significant insider or hedge fund activity.
The company's financials show a significant YoY revenue drop of -70.27%, a net income decline of -9.01%, and EPS down -12.50%. The stock also has a bearish technical setup and no recent trading signals.
In Q4 2025, revenue dropped to $338,000 (-70.27% YoY), net income fell to -$14.37M (-9.01% YoY), and EPS declined to -0.14 (-12.50% YoY). Gross margin remained flat at 100%.
No data on analyst ratings or price target changes is provided.
